By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    GSK deepens AI drug discovery bet with $110M Relation expansion
    By
    msadmin
    August 2, 2026
    Samsung’s Galaxy Ring wins first FDA nod for over-the-counter sleep apnea screening
    By
    msadmin
    August 2, 2026
    Most hospitals say infrastructure is not ready for on-site AI workloads
    By
    msadmin
    August 2, 2026
    Function Health banks $450M in non-dilutive cash for preventive care push
    By
    msadmin
    August 2, 2026
    OpenAI bets on academia with free frontier AI for 100,000 scientists
    By
    msadmin
    August 1, 2026
  • Spotlight
    SpotlightShow More
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
    ARPA-H Awards $160 Million for AI-Enabled Personalized Gene Editing to Tackle Rare Diseases
    By
    msadmin
    July 12, 2026
    Strategic healthcare AI governance framework abstract illustration
    Building a Resilient Healthcare AI Strategy: Insights from Industry Leaders
    By
    msadmin
    May 15, 2026
    Pharma AI Alliance Expands: Owkin and AstraZeneca Deploy New Drug Discovery Models
    By
    msadmin
    May 14, 2026
    7 Must-Attend MedTech Events in South Africa for 2025
    By
    Jostel Owusu
    August 9, 2025
  • Articles
    ArticlesShow More
    Teladoc puts 100 percent of fees at risk with new AI-powered platform
    By
    msadmin
    July 27, 2026
    Johns Hopkins finds frontier AI agents fail most complex health tasks
    By
    msadmin
    July 27, 2026
    Teladoc puts fees at risk in AI-powered virtual care platform relaunch
    By
    msadmin
    July 27, 2026
    AI tops global healthcare IT investment priorities, KLAS finds
    By
    msadmin
    July 22, 2026
    Hospital CEOs must own AI safety, not delegate it to IT
    By
    msadmin
    July 22, 2026
  • Events
    EventsShow More
    Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
    By
    msadmin
    June 19, 2026
    HIMSS APAC 2026: Re-engineering APAC Health Systems in the AI Era
    By
    msadmin
    June 9, 2026
    AIMed 2026: Bridging the Gap Between AI Promise and Clinical Reality in Kraków
    By
    msadmin
    April 30, 2026
    7 Must-Attend MedTech Events in South Africa for 2025
    By
    Jostel Owusu
    August 9, 2025
    Cleveland Clinic’s First AI Summit Signals Bold Future for Healthcare
    By
    msadmin
    July 19, 2025
  • About
    • Mission
    • Services
    • Contact
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • Events
  • About
  • Quick Links
    • Home
    • News & Alerts
    • Spotlight
    • Articles
    • Events
  • About MedSpark
    • Our Purpose & Vision
    • Services
    • Contact
Follow US
News & Alerts

Samsung’s Galaxy Ring wins first FDA nod for over-the-counter sleep apnea screening

Samsung's Galaxy Ring becomes the first over-the-counter smart ring cleared by the FDA to flag sleep apnea risk.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: August 2, 2026
Share
2 Min Read
SHARE

Samsung will bring an FDA-cleared Sleep Apnea Feature to the Galaxy Ring this fall, making it the first over-the-counter smart ring cleared to assess a user’s risk of the condition.

According to FDA records, Samsung submitted the Sleep Apnea Feature v2.0 for 510(k) clearance in March, and the agency determined it was substantially equivalent to a legally marketed device on July 20. The feature uses an AI algorithm to count breathing disruptions per hour and sorts results into three risk levels.

Users wear the ring for two nights within a 10-day period. The tool is meant to flag signs of moderate to severe obstructive sleep apnea in adults who have not yet been diagnosed, and Samsung stresses it does not provide a diagnosis or replace evaluation by a clinician.

Samsung digital health lead Sharanya Desai announced the feature at the Galaxy Unpacked event, saying the ring would become the first and only FDA-cleared over-the-counter ring device for sleep apnea risk detection.

The company’s Galaxy Watch sleep apnea feature received De Novo authorization in 2024, and Apple won FDA clearance for sleep apnea detection on the Apple Watch in September 2024. The ring clearance extends the category to a new form factor at the device’s $399 price point.

TAGGED:510(k)AI wearableDigital HealthFDA clearanceGalaxy RingSamsungsleep apnea
SOURCES:MobiHealthNews
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News
banner-medspark-horiz

You Might Also Like

News & Alerts

GSK deepens AI drug discovery bet with $110M Relation expansion

By
msadmin
August 2, 2026
News & Alerts

CHAI and The Joint Commission Partner to Launch AI Governance Playbooks for U.S. Healthcare Providers

By
Yu Chi Huang
June 16, 2025
News & Alerts

Insilico and SK Biopharm ink $2.5 billion AI drug discovery deal

By
msadmin
July 17, 2026
News & Alerts

Perci Health Secures £7.7M to Expand AI-Powered Virtual Cancer Clinic and Transform Post-Treatment Support

By
Yu Chi Huang
June 16, 2025

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal